Welcome to the Cell Therapy for Neurological Disorders Summit
The Cell Therapy for Neurological Disorders Summit is the definitive gathering for professionals dedicated to advancing cell therapies for complex neurological conditions. As 2024 becomes a pivotal year for breakthroughs in this field, the summit will focus on overcoming the unique challenges of bringing these therapies to patients.
This event unites leaders from top biotech companies and academic institutions to discuss the latest scientific developments, from improving delivery across the blood-brain barrier to enhancing the safety and efficacy of cell-based treatments. By attending, you'll gain access to cutting-edge insights and strategies that will help propel your projects forward.
Focused on the specific needs of the neurological cell therapy community, this summit is your key to staying ahead in the race to develop life-changing treatments for disorders like Alzheimer’s, Parkinson’s, ALS, and MS. Don’t miss this chance to be part of a transformative conversation that’s setting the future direction of neurological care.
Cell Therapy Companies By Disease Type
Top Reasons to Attend
Discover the breakthrough work of Kenai Therapeutics, as they showcase innovative iPSC technologies to combat Parkinson's Disease
Streamline your transition to the clinic with our dedicated workshop on how experts at UCSD, the Scripps Research Institute, and the Mayo Clinic are developing the next generation of preclinical models
Discuss with differing opinions on patient challenges like immunosuppression and the importance of placebos
Focus on regulatory challenges of taking a cell therapy for neurological conditions into the clinic with insights from the Chief Regulatory Officer of Aspen Neuroscience
Prepare for the future with panel discussions on the current neurology landscape and the next big indications for cell therapy drug developers to pursue with Vitro Biopharma
“This event brings together leading experts and advocates who are dedicated to advancing our understanding and treatment of neurological disorders through cutting-edge cell therapy”
_______________________________________
Xiaokui Zhang, Chief Scientific Officer, Aspen Neuroscience